Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Synthesis and biodistribution studies of (I-125)-iodoergoline derivatives

Conference · · J. Nucl. Med.; (United States)
OSTI ID:6857633
The relatively high uptake in rat and dog brains of (Se-75)-Selenopergolide reported earlier, has prompted the synthesis of four new ergoline analogs that can be labeled with I-123. The radioactive iodoergoline derivatives Ia and II were synthesized in a radiochemical yield of 80% and 30% respectively, by refluxing the corresponding 8..beta..-mesyl derivatives with (I-125)-NaI in absolute ethanol. Their chromatographic purification yielded no-carrier added compounds. Ib and Ic were synthesized in a radiochemical yield of 75% and 40% respectively, by refluxing the 8..beta..-(o-iodobenzoyl)- and the 8..beta..-(p-iodobenzenesulfonyl)-lysergol derivatives with (I-125)-NaI. Chromatographic purification yielded compounds with specific activities of --0.3 mCi/mg. Biodistribution studies performed in mature male rats after injection of 2-7 ..mu..Ci of the compounds, showed high uptake of Ia, Ib and II in the brain and adrenals up to 30 min. This data is in agreement with previously studied Se-75 labeled closely related derivatives. Compound II showed, at maximum uptake time, the highest target/non-target ratios. Complete chemical, radiochemical synthesis, and structure biodistribution relationships are presented to support the hypothesis that radiolabeled ergolines could potentially be used as dopamine receptor site mapping agents.
Research Organization:
Nuclear Pharmacy Programs, College of Pharmacy, Univ. of Oklahoma Health Sciences Center, Oklahoma City, OK
OSTI ID:
6857633
Report Number(s):
CONF-850611-
Conference Information:
Journal Name: J. Nucl. Med.; (United States) Journal Volume: 26:5
Country of Publication:
United States
Language:
English

Similar Records